Sonoma Pharmaceuticals Announces Management Changes
Sonoma Pharmaceuticals, Inc. (SNOA)
Last sonoma pharmaceuticals, inc. earnings: 2/14 05:13 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.sonomapharma.com
Company Research
Source: GlobeNewswire
Agreement with CEO and Interim CFO Bubba Sandford endsAmy Trombly Appointed as Interim CEO John Dal Poggetto Appointed as New CFO PETALUMA, Calif., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a specialty pharmaceutical Company dedicated to identifying, developing and commercializing unique, differentiated therapies to millions of patients living with chronic skin conditions, today announced the following management changes. Bubba Sandford left Sonoma on September 25 after nine months as CEO and Interim CFO after successfully evaluating the Company’s prospects while substantially reducing its cash burn. Mr. Sandford will remain on the Board of Directors for six months following his departure date. The Board of Directors named Amy Trombly as Sonoma’s Interim Chief Executive Officer and promoted John Dal Poggetto to Chief Financial Officer, effective immediately. The Board has begun the search for a new Chief Executive Officer with deep indust
Show less
Read more
Impact Snapshot
Event Time:
SNOA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SNOA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SNOA alerts
High impacting Sonoma Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
SNOA
News
- Sonoma Pharmaceuticals Announces Expansion of Negative-Pressure Wound Therapy Products for Use in the United States [Yahoo! Finance]Yahoo! Finance
- Sonoma Pharmaceuticals Announces Expansion of Negative-Pressure Wound Therapy Products for Use in the United StatesAccesswire
- Sonoma Pharmaceuticals Reports Recent Publication from Australia Highlighting Potential for Microdox in Managing Urinary Tract Infections [Yahoo! Finance]Yahoo! Finance
- Sonoma Pharmaceuticals Reports Recent Publication from Australia Highlighting Potential for Microdox in Managing Urinary Tract Infections Accesswire
- Sonoma Pharmaceuticals to Present at Trickle Research and LD Micro Investor Conferences [Yahoo! Finance]Yahoo! Finance
SNOA
Sec Filings
- 4/9/24 - Form 8-K
- 4/2/24 - Form 8-K
- 3/22/24 - Form 8-K
- SNOA's page on the SEC website